Insiders / Eric Easom
Eric Easom
CIK 1914503personinsiderbeneficial owner
Companies
1
First seen
Feb 13, 2026
Last activity
Mar 23, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| AN2 Therapeutics, Inc. · ANTX | 368,630 | — |
All securities held
1 position · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| AN2 Therapeutics, Inc. | Common Stock | 368,630 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 20, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Common Stock | $0 | +112K +43.78% | 368,630 0.98% of shares | low |
| Mar 19, 2026 | Other | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | -268K -100.00% | 0 0.00% of shares | low |
| Mar 19, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | +268K | 267,650 0.71% of shares | low |
| Mar 19, 2026 | Other | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | -225K -100.00% | 0 0.00% of shares | low |
| Mar 19, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | +225K | 225,000 0.60% of shares | low |
| Mar 19, 2026 | Other | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | -250K -100.00% | 0 0.00% of shares | low |
| Mar 19, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | +250K | 249,999 0.66% of shares | low |
| Feb 20, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | +225K | 224,500 0.59% of shares | low |